Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells.
Zubrilov I, Sagi-Assif O, Izraely S, Meshel T, Ben-Menahem S, Ginat R, Pasmanik-Chor M, Nahmias C, Couraud PO, Hoon DS, Witz IP.
Zubrilov I, et al. Among authors: meshel t.
Cancer Lett. 2015 May 28;361(1):86-96. doi: 10.1016/j.canlet.2015.02.041. Epub 2015 Feb 25.
Cancer Lett. 2015.
PMID: 25725450